Status:

RECRUITING

Intestinal Dysbiosis and BBB Integrity in Autism

Lead Sponsor:

University Hospital, Montpellier

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

LBPC, Inserm 1183, IRMB CHU Montpellier

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

6-16 years

Phase:

NA

Brief Summary

Autism Spectrum Disorder (ASD) is characterised by an impairment of social interactions and communication, associated with repetitive behaviour and restrictive interests. Clinical phenotypes of this n...

Detailed Description

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interactions and communication, associated with repetitive behaviors and restricted interests. The path...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Child from the ELENA cohort who received at least 3 years of follow-up in this cohort and a diagnosis of ASD
  • Aged 6 to 16 years
  • Living in Languedoc-Roussillon
  • Consent to participate in the study signed by the legal representative
  • Exclusion criteria:
  • Syndromic autism (neuroanatomical abnormality detected on brain MRI, severe neurological syndrome or polymalformative)
  • Known severe gastrointestinal pathology (such as celiac disease or Crohn's disease)
  • Other known severe chronic disease (e.g., diabetes)
  • Specific diet (gluten-free, casein-free, ketogenic, protein-enriched) within 6 months
  • Antibiotics taken within 2 months prior to inclusion
  • Probiotics taken in the 6 months prior to inclusion
  • Oxytocin intake in the 6 months prior to inclusion
  • ADOS Level Module 4 (due to the impossibility of calculating a ADOS-CSS score in this case)
  • Not affiliated to a French social security scheme or not beneficiaries of such a scheme
  • Refusal of blood test
  • Pregnant women

Exclusion

    Key Trial Info

    Start Date :

    April 26 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 26 2025

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT04321915

    Start Date

    April 26 2021

    End Date

    February 26 2025

    Last Update

    May 29 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centre de Ressources Autisme

    Montpellier, France, 34295